MA47607A - Synthèse à grande échelle d'arn messager - Google Patents

Synthèse à grande échelle d'arn messager

Info

Publication number
MA47607A
MA47607A MA047607A MA47607A MA47607A MA 47607 A MA47607 A MA 47607A MA 047607 A MA047607 A MA 047607A MA 47607 A MA47607 A MA 47607A MA 47607 A MA47607 A MA 47607A
Authority
MA
Morocco
Prior art keywords
arn
messenger
scale synthesis
synthesis
scale
Prior art date
Application number
MA047607A
Other languages
English (en)
Inventor
Jonathan Abysalh
Daniel Crawford
Frank Derosa
Anusha Dias
Michael Heartlein
Original Assignee
Translate Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translate Bio Inc filed Critical Translate Bio Inc
Publication of MA47607A publication Critical patent/MA47607A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1068—Template (nucleic acid) mediated chemical library synthesis, e.g. chemical and enzymatical DNA-templated organic molecule synthesis, libraries prepared by non ribosomal polypeptide synthesis [NRPS], DNA/RNA-polymerase mediated polypeptide synthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07006—DNA-directed RNA polymerase (2.7.7.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44756—Apparatus specially adapted therefor
    • G01N27/44773—Multi-stage electrophoresis, e.g. two-dimensional electrophoresis
    • G01N27/44778—Multi-stage electrophoresis, e.g. two-dimensional electrophoresis on a common gel carrier, i.e. 2D gel electrophoresis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Electrochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA047607A 2017-02-27 2018-02-27 Synthèse à grande échelle d'arn messager MA47607A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762464043P 2017-02-27 2017-02-27

Publications (1)

Publication Number Publication Date
MA47607A true MA47607A (fr) 2020-01-01

Family

ID=61800667

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047607A MA47607A (fr) 2017-02-27 2018-02-27 Synthèse à grande échelle d'arn messager

Country Status (10)

Country Link
US (2) US11560562B2 (fr)
EP (2) EP3585886B1 (fr)
AU (2) AU2018224325B2 (fr)
CA (1) CA3053814A1 (fr)
DK (1) DK3585886T5 (fr)
ES (1) ES2971902T3 (fr)
HU (1) HUE065140T2 (fr)
IL (2) IL310939B2 (fr)
MA (1) MA47607A (fr)
WO (1) WO2018157153A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4074693A1 (fr) 2011-06-08 2022-10-19 Translate Bio, Inc. Lipides clivables
EP3714048B1 (fr) 2017-11-22 2025-04-09 ModernaTX, Inc. Polynucléotides codant pour l'ornithine transcarbamylase pour le traitement de troubles du cycle de l'urée
MX2022007756A (es) 2019-12-20 2022-09-27 Translate Bio Inc Suministro rectal de arn mensajero.
JP2023508881A (ja) 2019-12-20 2023-03-06 トランスレイト バイオ, インコーポレイテッド Mrna担持脂質ナノ粒子を調製する改善されたプロセス
CA3170319A1 (fr) 2020-02-10 2021-08-19 Translate Bio, Inc. Procedes et compositions pour purification d'arn messager
BR112022016258A2 (pt) 2020-02-18 2022-10-18 Translate Bio Inc Processos melhorados para transcrição in vitro de rna mensageiro
CN115427021A (zh) 2020-02-25 2022-12-02 翻译生物公司 制备负载mrna的脂质纳米颗粒的改进方法
AU2021269042A1 (en) 2020-05-07 2023-02-02 Translate Bio, Inc. Optimized nucleotide sequences encoding SARS-CoV-2 antigens
WO2021226463A1 (fr) 2020-05-07 2021-11-11 Translate Bio, Inc. Composition et méthodes de traitement d'une dyskinésie ciliaire primitive
JP7873638B2 (ja) 2020-05-15 2026-06-12 トランスレイト バイオ, インコーポレイテッド mRNA送達のための脂質ナノ粒子製剤
CA3194863A1 (fr) 2020-10-06 2022-04-14 Shrirang KARVE Procede ameliore et formulation de nanoparticules lipidiques
US12678406B2 (en) 2020-10-12 2026-07-14 Translate Bio Inc. Process of preparing ice-based lipid nanoparticles
CA3198411A1 (fr) 2020-10-12 2022-04-21 Translate Bio, Inc. Procede ameliore de preparation de nanoparticules lipidiques chargees d'arnm
MX2023004371A (es) 2020-10-14 2023-07-26 George Mason Res Foundation Inc Lípidos ionizables, y métodos de fabricación y uso de los mismos.
CN116438298A (zh) * 2020-10-15 2023-07-14 翻译生物公司 信使rna的大规模合成
WO2022099003A1 (fr) * 2020-11-06 2022-05-12 Sanofi Nanoparticules lipidiques pour l'administration de vaccins à arnm
US20250268994A1 (en) 2021-03-25 2025-08-28 Translate Bio, Inc. Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion Thereof
CA3215606A1 (fr) 2021-04-19 2022-10-27 Shrirang KARVE Compositions ameliorees pour l'administration d'arnm
EP4362920A1 (fr) 2021-07-01 2024-05-08 Translate Bio, Inc. Compositions de livraison d'arnm
JP2024545572A (ja) 2021-11-10 2024-12-10 トランスレイト バイオ, インコーポレイテッド 原発性線毛機能不全の治療のための組成物及び方法
IL317499A (en) * 2022-07-01 2025-02-01 Arcturus Therapeutics Inc Improved methods for in vitro transcription
AU2023316794A1 (en) 2022-07-29 2025-03-13 Sanofi Pasteur Inc. Methods for ethanol-free mrna purification
EP4622630A1 (fr) 2022-11-21 2025-10-01 Translate Bio, Inc. Compositions de formulations de poudre sèche d'arn messager et leurs procédés d'utilisation
AU2023394992A1 (en) 2022-12-15 2025-07-31 Sanofi Pasteur Inc. Mrna encoding influenza virus-like particle
TW202438514A (zh) 2022-12-20 2024-10-01 法商賽諾菲公司 鼻病毒mrna疫苗
JP2026503216A (ja) 2022-12-23 2026-01-28 サノフィ パスツール インコーポレイテッド メッセンジャーrnaの最適化されたテーリング
WO2024141784A2 (fr) 2022-12-29 2024-07-04 Popvax Private Limited Vaccins et compositions à protection large contre les bètacoronavirus
EP4642481A2 (fr) 2022-12-29 2025-11-05 Popvax Private Limited Vaccins et agents thérapeutiques multicibles
JP2026508405A (ja) 2023-03-07 2026-03-10 サノフィ パスツール インコーポレイテッド Kp34ポリメラーゼを用いたメッセンジャーrnaの製造
MX2025012337A (es) 2023-04-17 2026-02-03 Sanofi Pasteur Inc Formulaciones de polvo seco reconstituibles y métodos de uso de las mismas
WO2025017151A1 (fr) 2023-07-18 2025-01-23 Sanofi Matrices d'arn messager codant pour le poly(a) stables
WO2025104351A1 (fr) 2023-11-17 2025-05-22 Sanofi Pasteur Inc. Dosages par clhp pour détecter de multiples constructions d'arnm
WO2026033123A1 (fr) 2024-08-08 2026-02-12 Sanofi Pasteur Inc. Formulations de nanoparticules lipidiques pour l'administration d'arnm
WO2026093322A1 (fr) 2024-10-28 2026-05-07 Sanofi Pasteur Inc. Constructions d'adn améliorées pour la fabrication d'arn messager par transcription in vitro

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2578685T3 (pl) 2005-08-23 2020-01-31 The Trustees Of The University Of Pennsylvania Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania
WO2009030254A1 (fr) 2007-09-04 2009-03-12 Curevac Gmbh Complexes d'arn et de peptides cationiques pour transfection et immunostimulation
EA022786B1 (ru) 2009-07-31 2016-03-31 Этрис Гмбх Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков
US8326547B2 (en) 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
SI2506857T1 (en) 2009-12-01 2018-08-31 Translate Bio, Inc. Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
US8853377B2 (en) 2010-11-30 2014-10-07 Shire Human Genetic Therapies, Inc. mRNA for use in treatment of human genetic diseases
KR20220025112A (ko) * 2011-06-08 2022-03-03 샤이어 휴먼 지네틱 테라피즈 인크. Mrna 전달을 위한 지질 나노입자 조성물 및 방법
EA201591283A1 (ru) 2013-03-14 2016-02-29 Шир Хьюман Дженетик Терапис, Инк. Количественная оценка эффективности кэп матричной рнк
EA201591229A1 (ru) 2013-03-14 2016-01-29 Шир Хьюман Дженетик Терапис, Инк. Способы очистки матричной рнк
EP4729528A3 (fr) 2014-04-25 2026-06-24 Translate Bio, Inc. Procédés de purification d'arn messager
SG11201608605QA (en) * 2014-06-10 2016-12-29 Curevac Ag Methods and means for enhancing rna production
EP3270894B1 (fr) * 2015-03-19 2021-02-24 Translate Bio, Inc. Thérapie d'arnm pour maladie de pompe
WO2016180430A1 (fr) * 2015-05-08 2016-11-17 Curevac Ag Procédé de production d'arn
MX2019010155A (es) * 2017-02-27 2020-12-10 Translate Bio Inc Arnm de cftr optimizado por codón novedoso.

Also Published As

Publication number Publication date
IL310939B1 (en) 2025-09-01
IL268892B1 (en) 2024-03-01
EP3585886B1 (fr) 2023-11-22
DK3585886T5 (da) 2024-09-02
IL310939B2 (en) 2026-01-01
HUE065140T2 (hu) 2024-05-28
CA3053814A1 (fr) 2018-08-30
WO2018157153A1 (fr) 2018-08-30
IL310939A (en) 2024-04-01
IL268892B2 (en) 2024-07-01
US11560562B2 (en) 2023-01-24
IL268892A (en) 2019-10-31
AU2018224325A1 (en) 2019-09-12
AU2018224325B2 (en) 2024-05-02
ES2971902T3 (es) 2024-06-10
EP4105326A1 (fr) 2022-12-21
US20240018514A1 (en) 2024-01-18
EP3585886A1 (fr) 2020-01-01
AU2024205244A1 (en) 2024-08-22
DK3585886T3 (da) 2024-02-19
US20180258423A1 (en) 2018-09-13

Similar Documents

Publication Publication Date Title
IL268892A (en) Large scale synthesis of messenger rna
EP3645146A4 (fr) Synthèse d'oligosaccharides
EP3658885A4 (fr) Tube d'isolement
IL268856A (en) Methods for purification of messenger rna
EP3796668A4 (fr) Écouteur
EP3607587A4 (fr) Panneau d'affichage
IL266212A (en) Direction for arrival assessment
EP3341861A4 (fr) Recommandation de vidéos d'après des titres de vidéos
MA46761A (fr) Administration sous-cutanée d'arn messager
EP3563166A4 (fr) Réseaux d'antennes
EP3696336A4 (fr) Structure d'assemblage pour poutre en h
EP3394754A4 (fr) Planification d'applications fortement parallèles
EP3448417A4 (fr) Conjugués dimères d'insuline-incrétine
EP3658683A4 (fr) Découverte d'épitopes à médiation par trogocytose
EP3571854A4 (fr) Extension de point de rendu audio spatial
EP3506254A4 (fr) Structure d'insonorisation
EP3377981A4 (fr) Planification des ressources d'un instrument
EP3347334A4 (fr) Déshydrohalogénation d'hydrochlorofluorocarbones
EP3525479A4 (fr) Casque d'écoute
EP3598705A4 (fr) Commande d'acheminement
EP3612516A4 (fr) Synthèse de mésotrione
EP3799594A4 (fr) Production d'oligosaccharides
EP3467761A4 (fr) Serveur d'envoi de corbillard
MA53238A (fr) Formules d'ag10
MA42690A (fr) Micropropagation d'un dattier abada